Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy

NCT07526857 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy, DR

Interventions

DRUG: Faricimab Injection [Vabysmo]
DRUG: Aflibercept (2.0 mg)

Sponsor

Federico II University